The recent coronavirus disease 2019 (COVID-19) epidemic is spreading all over the world.
By March 23, over 300,000 patients had been confirmed and almost 15,000 died because of …

The pandemic caused by the novel coronavirus, called SARS-CoV-2, affected more than
one million people around the world. The COVID-19, the acronym derived from the …

The global pandemic of the new coronavirus SARS-CoV-2 not only has medical, economic
and social but also historical significance. In many parts of the world, the exponential …

As yet, there is no specific therapy for covid-19. Thus, as an alternative, there is the
transfusion of plasma obtained from individuals who are convalescent from covid-19 …

168 Letter to the Editor/Transfusion Clinique et Biologique 27 (2020) 165–171 tional studies
have stimulated global interest in the organisation of collection systems for this …

As transfusion medicine specialists we understood the potential that convalescent plasma
(CCP) could play early in the management of patients with COVID-19. However, with no …

• Previous studies of convalescent plasma in treating other viral diseases have identified
factors to consider when designing treatment protocols, including timing of administration …

Background Convalescent plasma has been used for a long time for the treatment of various
infectious diseases. The principle is to collect antibody-containing plasma from recovered …

Convalescent plasma (CP) transfusion has been indicated as a promising therapy in the
treatment for other emerging viral infections. However, the quality control of CP and …

Aim Convalescent plasma proved to increase survival rates in other severe viral infections.
Therefore, convalescent plasma could be a promising treatment option for severe COVID-19 …